Anderson Financial Strategies LLC lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 51.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 615 shares of the medical equipment provider’s stock after selling 660 shares during the period. Anderson Financial Strategies LLC’s holdings in Intuitive Surgical were worth $334,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Norway Savings Bank increased its stake in Intuitive Surgical by 53.4% during the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after purchasing an additional 910 shares in the last quarter. Trust Co. of Oklahoma purchased a new stake in shares of Intuitive Surgical in the second quarter worth about $363,000. IronOak Wealth LLC. purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at approximately $1,099,000. Amalgamated Bank raised its position in shares of Intuitive Surgical by 2.2% in the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after acquiring an additional 1,772 shares during the period. Finally, Neville Rodie & Shaw Inc. raised its holdings in Intuitive Surgical by 11.9% in the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock worth $5,666,000 after purchasing an additional 1,110 shares during the period. 83.64% of the stock is currently owned by institutional investors.
Intuitive Surgical Stock Performance
ISRG opened at $546.71 on Tuesday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The business’s 50-day simple moving average is $484.04 and its 200-day simple moving average is $503.21. The company has a market cap of $195.98 billion, a P/E ratio of 72.32, a PEG ratio of 4.94 and a beta of 1.62.
Analyst Ratings Changes
Several equities analysts have issued reports on the stock. BTIG Research increased their price objective on shares of Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Hsbc Global Res upgraded Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. HSBC raised their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Leerink Partners boosted their price objective on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Finally, Royal Bank Of Canada set a $625.00 price target on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.
Get Our Latest Stock Analysis on ISRG
Insider Buying and Selling
In other news, VP Fredrik Widman sold 2,067 shares of the stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total transaction of $1,136,850.00. Following the completion of the sale, the vice president owned 473 shares in the company, valued at approximately $260,150. This represents a 81.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Craig H. Barratt sold 750 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $435,000.00. The SEC filing for this sale provides additional information. Insiders have sold 116,164 shares of company stock valued at $61,916,172 in the last 90 days. Company insiders own 0.70% of the company’s stock.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- What is the Australian Securities Exchange (ASX)
- Whirlpool’s Worst May Be Over—Upside Opportunity Ahead
- Short Selling – The Pros and Cons
- These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter
- Canadian Penny Stocks: Can They Make You Rich?
- How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
